Biora Therapeutics reports progress on BT-600 and BioJet platforms By Investing.com
Biora Therapeutics has reported significant advancements in its BT-600 program and BioJet platform during its recent earnings call. The company announced successful Phase I clinical trial results for its BT-600 program, utilizing the…
